PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PixarBio Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10950
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PixarBio Corp (PixarBio), formerly BMP Holdings Inc is a biotechnology company that discovers and develops novel neurological drug delivery systems for postsurgical pain, acute pain, and chronic pain. The company offers research and commercial development of targeted drug delivery systems, biologics and devices to treat Parkinson’s disease, pain, epilepsy, and spinal cord injury. Its lead product platform NeuroRelease facilitated the sustained release of non-addictive and non-opiate drugs in post-operative, acute and chronic pain in pre-clinical models. PixarBio also helps reduce pain signals without impeding locomotion signals. The company has its operations in New Jersey, New York, and New Hampshire, the US. PixarBio is headquartered in Fort Lee, New Jersey, the US.

PixarBio Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PixarBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PixarBio Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PixarBio Raises USD7.2 Million in Venture Financing 10
Merger 11
BMP Holdings Merges with PixarBio in Reverse Merger Transaction 11
Equity Offering 12
Pixarbio Raises USD0.4 Million in Private Placement 12
PixarBio Raises USD0.8 Million in Financing 13
PixarBio Raises USD7.2 Million in Private Placement of Shares and Warrants 14
PixarBio Corp – Key Competitors 15
PixarBio Corp – Key Employees 16
PixarBio Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
01/27/2017: PixarBio CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 NobleCon13 Investor Conference in Boca Raton, FL on Monday, January 30, 2017 18
01/09/2017: PixarBio Expands Non-Opiate R&D Portfolio For Pain with Steroid Injections; Collaborates for Clinical cGMP Manufacturing, and Grooms Team For Clinical Studies of NeuroRelease Post-Surgical Pain Treatments 14-Day, 7-Day, and 3-Day 19
01/05/2017: PixarBio CEO Frank Reynolds to Present NeuroRelease a Morphine Replacement, Non-Opiate, Non Addictive Pain Treatment at the 2017 Biotech Showcase in San Francisco 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PixarBio Corp, Pharmaceuticals & Healthcare, Key Facts 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Deals By Therapy Area, 2012 to YTD 2018 8
PixarBio Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PixarBio Raises USD7.2 Million in Venture Financing 10
BMP Holdings Merges with PixarBio in Reverse Merger Transaction 11
Pixarbio Raises USD0.4 Million in Private Placement 12
PixarBio Raises USD0.8 Million in Financing 13
PixarBio Raises USD7.2 Million in Private Placement of Shares and Warrants 14
PixarBio Corp, Key Competitors 15
PixarBio Corp, Key Employees 16
PixarBio Corp, Other Locations 17
PixarBio Corp, Subsidiaries 17

List of Figures
PixarBio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PixarBio Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PixarBio Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PixarBio Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C-Rad AB (CRAD B):企業の財務・戦略的SWOT分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments . The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems . Its products include sentinel 4DCT, catalyst H …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …
  • International Data Group:戦略・SWOT・企業財務分析
    International Data Group - Strategy, SWOT and Corporate Finance Report Summary International Data Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CVS Health Corp (CVS):企業の財務・戦略的SWOT分析
    CVS Health Corp (CVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vectren Corp (VVC):企業の財務・戦略的SWOT分析
    Vectren Corp (VVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • InspireMD Inc (NSPR):医療機器:M&Aディール及び事業提携情報
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Janssen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a healthcare products provider that offers various medicines. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental …
  • Sogefi S.p.A:企業の戦略・SWOT・財務情報
    Sogefi S.p.A - Strategy, SWOT and Corporate Finance Report Summary Sogefi S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Corindus Vascular Robotics Inc (CVRS):企業の財務・戦略的SWOT分析
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • Active Motif Inc-製薬・医療分野:企業M&A・提携分析
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products comprise antibodies, extracts, fluorescent dyes, kits, reporter assays, molecules and recombinant proteins. It offers products for transcriptional regulation, …
  • UTS Biogastechnik GmbH:企業の戦略的SWOT分析
    UTS Biogastechnik GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Prakash Constrowell Limited
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Troy Resources Limited:企業の戦略・SWOT・財務分析
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cibis SpA:企業の戦略・SWOT・財務分析
    Cibis SpA - Strategy, SWOT and Corporate Finance Report Summary Cibis SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Companhia de Transmissao de Energia Eletrica Paulista (TRPL4):企業の財務・戦略的SWOT分析
    Summary Companhia de Transmissao de Energia Eletrica Paulista (CTEEP) a subsidiary of Interconexion Electrica SA ESP, is an electric utility service provider that produces and distributes electricity. The utility owns and operates power generation plants and transmission lines and supplies electrici …
  • Cardiva Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • AstraZeneca PLC:企業の戦略・SWOT・財務情報
    AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report Summary AstraZeneca PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Centice Corporation-医療機器分野:企業M&A・提携分析
    Summary Centice Corporation (Centice) is a medical and electronic equipment company which designs, develops and offers advance sensors for various applications. The company’s products include BTL-200N, MFL-300N, BTL-200P, MFL-300P, and MFL-3000. It also provides illicit substances, prescription drug …
  • Paz Oil Co Ltd (PZOL):企業の財務・戦略的SWOT分析
    Paz Oil Co Ltd (PZOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Antisense Therapeutics Ltd (ANP):製薬・医療:M&Aディール及び事業提携情報
    Summary Antisense Therapeutics Ltd (Antisense Therapeutics) is clinical staged biopharmaceutical company which focuses on the discovery, development and commercialization of second generation antisense pharmaceuticals for various medical conditions that have large unmet medical needs. It focuses on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆